Placebo controlled, randomized trial, comparing the efficacy of white light cystoscopy with the fluorescence cystoscopy with the use of hexaminolevulinate, regarding the diagnosis and treatment of bladder cancer

Placebo controlled, randomized trial, comparing the efficacy of white light cystoscopy with the fluorescence cystoscopy with the use of hexaminolevulinate, regarding the diagnosis and treatment of bladder cancer - Fluorescence cystoscopy with hexaminolevulinate

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008176

Enrollment

100

Registered

2012-06-15

Start date

2008-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

transurethral resection of bladder cancer with the use of hexaminolevulinate transurethral resection of bladder cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: suspected or existing superficial bladder cancer

Exclusion criteria

Exclusion criteria: haematuria, porfyria

Design outcomes

Primary

Measure	Time frame
To estimate the sensitivity and specificity of the method To indentify, other than cancer, lesions of urothelium giving positive fluorescence To indentify the degree and how this method changes the way of transurethral resection of bladder cancer in every day clinical practice To prove if this method changes the overall treatment of patients To prove if this method helps the surgeon to improve his transurethral resection outcome To find out if it reduces the recurrence rate of the disease	—

Measure

Time frame

To estimate the sensitivity and specificity of the method To indentify, other than cancer, lesions of urothelium giving positive fluorescence To indentify the degree and how this method changes the way of transurethral resection of bladder cancer in every day clinical practice To prove if this method changes the overall treatment of patients To prove if this method helps the surgeon to improve his transurethral resection outcome To find out if it reduces the recurrence rate of the disease

—

Countries

Europe

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026